Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen

Affiliations

• ¹ Institut Universitaire Cancer-Oncopole, CHU Toulouse, INSERM U1037, Toulouse, France.
• ² LYSARC, Pierre Bénite, France.
• ³ Hospices Civils De Lyon, Pierre Bénite, France.
• ⁴ Genentech Inc., South San Francisco, California, USA.
• ⁵ Centre Léon Bérard, Lyon, France.
• ⁶ Institut Gustave Roussy, Villejuif, France.
• ⁷ Centre Hospitalier Pitié-Salpêtriére, Paris, France.
• ⁸ Memorial Sloan Kettering Cancer Center, New York, New York, USA.
• ⁹ Hôpital Claude Huriez, Lille, France.
• ¹⁰ Institut Paoli-Calmettes, CRCM and Aix-Marseille University, Marseille, France.